Cancer
Researchers from Kinnaird College for Women in Lahore, Pakistan, have made a significant breakthrough in cancer treatment by exploring the potential of selenium nanoparticles (SeNPs) as a novel therapeutic tool. According to a review published in Cancer Reports, SeNPs have the ability to selectively target malignant cells, modulate redox status,
Cancer
Research presented from Memorial Sloan-Kettering Cancer Center highlights the potential association between the use of dupilumab, a monoclonal antibody inhibiting interleukin-4 receptor alpha (IL-4Ra) and interleukin-13 receptor (IL-13R), and the development of cutaneous T-cell lymphoma (CTCL) in patients with atopic dermatitis (AD). The study's authors emphasize that while
Cancer
New research from the Victor Babes University of Medicine and Pharmacy in Timisoara, Romania, has highlighted the potential of Sodium-glucose cotransporter-2 (SGLT2) inhibitors in reducing cardiac toxicity associated with cancer treatment. According to the study, SGLT2 inhibitors have shown pleiotropic cardioprotective effects, including reduced oxidative stress, inflammation, and myocardial remodeling,
Cancer
Research at Jinzhou Medical University has provided new insights into the role of Src homology phosphotyrosyl phosphatase 2 (SHP2) in cancer therapy. According to a recent study, SHP2 modulators have shown promise as a tumor therapeutic target due to their ability to regulate tumor cell growth and proliferation, as well
Cancer
Research has been conducted at the Zhejiang Province in the People's Republic of China, highlighting the critical role of the microbiota in cancer therapy. The investigators have found that the microbiota plays a vital role in maintaining host health through intricate interactions with the immune system. This symbiotic
Cancer
Researchers at New York University's Tandon School of Engineering have made significant strides in developing cancer-on-a-chip technology, which has the potential to revolutionize the field of precision cancer medicine. This innovative approach involves creating microphysiological systems that closely mimic the complex tumor microenvironment, enabling more accurate disease modeling
Cancer
Researchers at Zhejiang Chinese Medical University have developed virus-mimic nanoparticles that exhibit enhanced permeability, active targeting ability, and smart responsiveness, demonstrating improved cancer therapy efficacy and biocompatibility. These nanoparticles, inspired by viral structures, were designed to target tumor cells and release cancer-fighting agents. The study's findings suggest that
Cancer
Floridan physicians and researchers have made significant contributions to the field of cancer care, presenting cutting-edge studies at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting. The meeting, which brings together oncology professionals from around the world, features research conducted at Florida Cancer Specialists & Research Institute (FCS)
Cancer
Researchers have developed a droplet-based microfluidic platform to track and analyze the behavior of natural killer (NK) cells, a crucial component of the immune system. This innovative platform monitors NK cell-mediated cytotoxicity against K562 cancer cells in real-time, providing valuable insights into the mechanisms of NK cell function. The study
Cancer
Pharmac, New Zealand's public healthcare provider, has announced the funding of new cancer treatments and the expansion of existing ones, promising improved access for thousands of patients. The move includes funding for immune checkpoint inhibitors, targeted cancer medicines, and antibiotics to combat antibiotic-resistant infections. Pharmac's decision
Cancer
Researchers from Tianjin University have made a significant breakthrough in cancer therapy by developing a nanomedicine that can amplify oxidative stress, leading to potent anticancer activity. The new approach combines chemotherapy and photodynamic therapy to address the limitations of single modal therapies and improve therapeutic outcomes. The nanomedicine, which is
Cancer
A groundbreaking study from University College Dublin has unveiled the enormous potential of Artificial Intelligence (AI) in transforming medical imaging for patients with cancer. According to the research, AI can significantly enhance the accuracy and efficiency of cardiotoxicity assessments in patients undergoing cancer therapy. The systematic review, which analyzed seven
